+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Point of Care (PoC) Molecular Diagnostics Market 2020-2030 by Product (Assays, Instruments, Software), Technology (PCR, INAAT, Microarray), Application, End User, and Region: Trend Forecast and Growth Opportunity

  • ID: 5157161
  • Report
  • September 2020
  • Region: Global
  • 183 pages
  • GMD Research
1 of 4

Order now to receive an updated version of this report covering the impact of COVID-19.

Enquire Now

FEATURED COMPANIES

  • Abacus Diagnostica Oy
  • Biocartis Group NV
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Meridian Bioscience Inc.
  • QuantuMDx Group Ltd.
  • MORE
Global PoC molecular diagnostics market will reach $5,665.3 million by 2030, growing by 13.5% annually over 2020-2030 driven by increase in adoption of personalized medicine and surge in usage of PoC molecular diagnostics for drug discovery and development amid COVID-19 pandemic.

Highlighted with 87 tables and 86 figures, this 183-page report “Global Point of Care (PoC) Molecular Diagnostics Market 2020-2030 by Product (Assays, Instruments, Software), Technology (PCR, INAAT, Microarray), Application, End User, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global PoC molecular diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year.

In-depth qualitative analyses include identification and investigation of the following aspects:
  • Market Structure
  • Growth Drivers
  • Restraints and Challenges
  • Emerging Product Trends & Market Opportunities
  • Porter’s Five Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global PoC molecular diagnostics market in every aspect of the classification from perspectives of Product, Technology, Application, End User, and Region.

Based on Product, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
  • Kits & Assays
  • Analyzers & Instruments
  • Software & Services
Based on Technology, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Polymerase Chain Reaction (PCR)
  • Real-Time PCR (rt-PCR)
  • Digital PCR (d-PCR)
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Genetic Sequencing-based Technology
  • Microarray-based Technology
  • Other Technologies
Based on Application, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Infectious Disease
  • Respiratory Infections
  • Hospital Acquired Infections
  • Sexually Transmitted Infections
  • Gastrointestinal Infections
  • Oncology
  • Hepatitis
  • Prenatal/Neonatal Testing
  • Other Applications
Based on End User, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
  • Hospitals
  • Clinics & Diagnostic Centers
  • Research and Academic Institutes
  • Other End Users
Geographically, the following regions together with the listed national/local markets are fully investigated:
  • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
  • Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
  • North America (U.S., Canada, and Mexico)
  • South America (Brazil, Chile, Argentina, Rest of South America)
  • MEA (Saudi Arabia, UAE, South Africa)
For each aforementioned region and country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Product, Technology, and Application over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in global PoC molecular diagnostics market are assayed quantitatively and qualitatively through a Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):
  • Abacus Diagnostica Oy
  • Abbott Laboratories
  • Alere Inc.
  • Biocartis Group NV
  • Biomerieux SA
  • Bio-Rad Laboratories Inc
  • Danaher Corporation
  • DiaSorin S.p.A
  • DxNA LLC.
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Luminex Corporation
  • Meridian Bioscience Inc.
  • Mesa Biotech Inc.
  • QIAGEN N.V.
  • QuantuMDx Group Ltd.
  • Quidel Corporation
  • Spartan Biosciences Inc.
  • Thermo Fisher Scientific
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abacus Diagnostica Oy
  • Biocartis Group NV
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Meridian Bioscience Inc.
  • QuantuMDx Group Ltd.
  • MORE
1 Introduction
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary

2 Market Overview and Dynamics
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Five Forces Analysis

3 Segmentation of Global Market by Product
3.1 Market Overview by Product
3.2 Kits & Assays
3.3 Analyzers & Instruments
3.4 Software & Services

4 Segmentation of Global Market by Technology
4.1 Market Overview by Technology
4.2 Polymerase Chain Reaction (PCR)
4.2.1 Real-Time PCR (rt-PCR)
4.2.2 Digital PCR (d-PCR)
4.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
4.4 Genetic Sequencing-based Technology
4.5 Microarray-based Technology
4.6 Other Technologies

5 Segmentation of Global Market by Application
5.1 Market Overview by Application
5.2 Infectious Disease
5.2.1 Respiratory Infections
5.2.2 Hospital Acquired Infections
5.2.3 Sexually Transmitted Infections
5.3 Gastrointestinal Infections
5.4 Oncology
5.5 Hepatitis
5.6 Prenatal/Neonatal Testing
5.7 Other Applications

6 Segmentation of Global Market by End User
6.1 Market Overview by End User
6.2 Hospitals
6.3 Clinics & Diagnostic Centers
6.4 Research and Academic Institutes
6.5 Other End Users

7 Segmentation of Global Market by Region
7.1 Geographic Market Overview 2019-2030
7.2 North America Market 2019-2030 by Country
7.2.1 Overview of North America Market
7.2.2 U.S.
7.2.3 Canada
7.2.4 Mexico
7.3 European Market 2019-2030 by Country
7.3.1 Overview of European Market
7.3.2 Germany
7.3.3 UK
7.3.4 France
7.3.5 Spain
7.3.6 Italy
7.3.7 Russia
7.3.8 Rest of European Market
7.4 Asia-Pacific Market 2019-2030 by Country
7.4.1 Overview of Asia-Pacific Market
7.4.2 Japan
7.4.3 China
7.4.4 Australia
7.4.5 India
7.4.6 South Korea
7.4.7 Rest of APAC Region
7.5 South America Market 2019-2030 by Country
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Chile
7.5.4 Rest of South America Market
7.6 MEA Market 2019-2030 by Country
7.6.1 UAE
7.6.2 Saudi Arabia
7.6.3 South Africa
7.6.4 Other National Markets

8 Competitive Landscape
8.1 Overview of Key Vendors
8.2 New Product Launch, Partnership, Investment, and M&A
8.3 Company Profiles
  • Abacus Diagnostica Oy
  • Abbott Laboratories
  • Alere Inc.
  • Biocartis Group NV
  • Biomerieux SA
  • Bio-Rad Laboratories Inc
  • Danaher Corporation
  • DiaSorin S.p.A
  • DxNA LLC.
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Luminex Corporation
  • Meridian Bioscience Inc.
  • Mesa Biotech Inc.
  • QIAGEN N.V.
  • QuantuMDx Group Ltd.
  • Quidel Corporation
  • Spartan Biosciences Inc.
  • Thermo Fisher Scientific
9 Investing in Global Market: Risk Assessment and Management
9.1 Risk Evaluation of Global Market
9.2 Critical Success Factors (CSFs)

List of Tables
Table 1. Snapshot of Global Point of Care (PoC) Molecular Diagnostics Market, 2019-2030
Table 2. Growth Rate of World Real GDP, 2017-2021
Table 3. Main Product Trends and Market Opportunities in Global Point of Care (PoC) Molecular Diagnostics Market
Table 4. Global Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn
Table 5. Global Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn
Table 6. Global Point of Care (PoC) Molecular Diagnostics Market: Polymerase Chain Reaction (PCR) by Type, 2019-2030, $ mn
Table 7. Global Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn
Table 8. Global Point of Care (PoC) Molecular Diagnostics Market: Infectious Disease by Type, 2019-2030, $ mn
Table 9. Global Point of Care (PoC) Molecular Diagnostics Market by End User, 2019-2030, $ mn
Table 10. Global Point of Care (PoC) Molecular Diagnostics Market by Region, 2019-2030, $ mn
Table 11. Total Health Expenditure per capita in PPP International U.S. Dollars by Country
Table 12. Leading National Point of Care (PoC) Molecular Diagnostics Market, 2019 and 2030, $ mn
Table 13. North America Point of Care (PoC) Molecular Diagnostics Market by Country, 2019-2030, $ mn
Table 14. U.S. Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn
Table 15. U.S. Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn
Table 16. U.S. Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn
Table 17. Canada Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn
Table 18. Canada Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn
Table 19. Canada Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn
Table 20. Mexico Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn
Table 21. Mexico Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn
Table 22. Mexico Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn
Table 23. Europe Point of Care (PoC) Molecular Diagnostics Market by Country, 2019-2030, $ mn
Table 24. Germany Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn
Table 25. Germany Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn
Table 26. Germany Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn
Table 27. UK Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn
Table 28. UK Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn
Table 29. UK Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn
Table 30. France Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn
Table 31. France Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn
Table 32. France Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn
Table 33. Spain Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn
Table 34. Spain Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn
Table 35. Spain Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn
Table 36. Italy Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn
Table 37. Italy Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn
Table 38. Italy Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn
Table 39. Russia Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn
Table 40. Russia Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn
Table 41. Russia Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn
Table 42. Point of Care (PoC) Molecular Diagnostics Market in Rest of Europe by Country, 2019-2030, $ mn
Table 43. APAC Point of Care (PoC) Molecular Diagnostics Market by Country, 2019-2030, $ mn
Table 44. Japan Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn
Table 45. Japan Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn
Table 46. Japan Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn
Table 47. China Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn
Table 48. China Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn
Table 49. China Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn
Table 50. Australia Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn
Table 51. Australia Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn
Table 52. Australia Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn
Table 53. India Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn
Table 54. India Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn
Table 55. India Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn
Table 56. South Korea Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn
Table 57. South Korea Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn
Table 58. South Korea Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn
Table 59. Point of Care (PoC) Molecular Diagnostics Market in Rest of APAC by Country, 2019-2030, $ mn
Table 60. South America Point of Care (PoC) Molecular Diagnostics Market by Country, 2019-2030, $ mn
Table 61. Argentina Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn
Table 62. Argentina Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn
Table 63. Argentina Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn
Table 64. Brazil Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn
Table 65. Brazil Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn
Table 66. Brazil Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn
Table 67. Chile Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn
Table 68. Chile Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn
Table 69. Chile Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn
Table 70. MEA Point of Care (PoC) Molecular Diagnostics Market by Country, 2019-2030, $ mn
Table 71. UAE Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn
Table 72. UAE Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn
Table 73. UAE Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn
Table 74. Saudi Arabia Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn
Table 75. Saudi Arabia Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn
Table 76. Saudi Arabia Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn
Table 77. South Africa Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn
Table 78. South Africa Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn
Table 79. South Africa Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn
Table 80. Breakdown of Global Market by Key Vendor, 2019, %
Table 81. Abacus Diagnostica Oy: Company Snapshot
Table 82. Abacus Diagnostica Oy: Business Segmentation
Table 83. Abacus Diagnostica Oy: Product Portfolio
Table 84. Abacus Diagnostica Oy: Revenue, 2016-2018, $ mn
Table 85. Abacus Diagnostica Oy: Recent Developments
Table 86. Risk Evaluation for Investing in Global Market, 2019-2030
Table 87. Critical Success Factors and Key Takeaways

List of Figures
Figure 1. Research Method Flow Chart
Figure 2. Breakdown of Primary Research
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 4. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030
Figure 5. Global Point of Care (PoC) Molecular Diagnostics Market, 2019-2030, $ mn
Figure 6. Impact of COVID-19 on Business
Figure 7. Primary Drivers and Impact Factors of Global Point of Care (PoC) Molecular Diagnostics Market
Figure 8. World Number of Deaths by Cause in 2017
Figure 9. World Number of Deaths from Cancers in 2017
Figure 10. Primary Restraints and Impact Factors of Global Point of Care (PoC) Molecular Diagnostics Market
Figure 11. Investment Opportunity Analysis
Figure 12. Porter’s Five Forces Analysis of Global Point of Care (PoC) Molecular Diagnostics Market
Figure 13. Breakdown of Global Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, % of Revenue
Figure 14. Global Addressable Market Cap in 2020-2030 by Product, Value ($ mn) and Share (%)
Figure 15. Global Point of Care (PoC) Molecular Diagnostics Market: Kits & Assays, 2019-2030, $ mn
Figure 16. Global Point of Care (PoC) Molecular Diagnostics Market: Analyzers & Instruments, 2019-2030, $ mn
Figure 17. Global Point of Care (PoC) Molecular Diagnostics Market: Software & Services, 2019-2030, $ mn
Figure 18. Breakdown of Global Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, % of Sales Revenue
Figure 19. Global Addressable Market Cap in 2020-2030 by Technology, Value ($ mn) and Share (%)
Figure 20. Global Point of Care (PoC) Molecular Diagnostics Market: Polymerase Chain Reaction (PCR), 2019-2030, $ mn
Figure 21. Global Point of Care (PoC) Molecular Diagnostics Market: Real-Time PCR (rt-PCR), 2019-2030, $ mn
Figure 22. Global Point of Care (PoC) Molecular Diagnostics Market: Digital PCR (d-PCR), 2019-2030, $ mn
Figure 23. Global Point of Care (PoC) Molecular Diagnostics Market: Isothermal Nucleic Acid Amplification Technology (INAAT), 2019-2030, $ mn
Figure 24. Global Point of Care (PoC) Molecular Diagnostics Market: Genetic Sequencing-based Technology, 2019-2030, $ mn
Figure 25. Global Point of Care (PoC) Molecular Diagnostics Market: Microarray-based Technology, 2019-2030, $ mn
Figure 26. Global Point of Care (PoC) Molecular Diagnostics Market: Other Technologies, 2019-2030, $ mn
Figure 27. Breakdown of Global Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, % of Sales Revenue
Figure 28. Global Addressable Market Cap in 2020-2030 by Application, Value ($ mn) and Share (%)
Figure 29. Global Point of Care (PoC) Molecular Diagnostics Market: Infectious Disease, 2019-2030, $ mn
Figure 30. Global Point of Care (PoC) Molecular Diagnostics Market: Respiratory Infections, 2019-2030, $ mn
Figure 31. Global Point of Care (PoC) Molecular Diagnostics Market: Hospital Acquired Infections, 2019-2030, $ mn
Figure 32. Global Point of Care (PoC) Molecular Diagnostics Market: Sexually Transmitted Infections, 2019-2030, $ mn
Figure 33. Global Point of Care (PoC) Molecular Diagnostics Market: Gastrointestinal Infections, 2019-2030, $ mn
Figure 34. Global Point of Care (PoC) Molecular Diagnostics Market: Oncology, 2019-2030, $ mn
Figure 35. Global Point of Care (PoC) Molecular Diagnostics Market: Hepatitis, 2019-2030, $ mn
Figure 36. Global Point of Care (PoC) Molecular Diagnostics Market: Prenatal/Neonatal Testing, 2019-2030, $ mn
Figure 37. Global Point of Care (PoC) Molecular Diagnostics Market: Other Applications, 2019-2030, $ mn
Figure 38. Breakdown of Global Point of Care (PoC) Molecular Diagnostics Market by End User, 2019-2030, % of Revenue
Figure 39. Global Addressable Market Cap in 2020-2030 by End User, Value ($ mn) and Share (%)
Figure 40. Global Point of Care (PoC) Molecular Diagnostics Market: Hospitals, 2019-2030, $ mn
Figure 41. Global Point of Care (PoC) Molecular Diagnostics Market: Clinics & Diagnostic Centers, 2019-2030, $ mn
Figure 42. Global Point of Care (PoC) Molecular Diagnostics Market: Research and Academic Institutes, 2019-2030, $ mn
Figure 43. Global Point of Care (PoC) Molecular Diagnostics Market: Other End Users, 2019-2030, $ mn
Figure 44. Global Market Snapshot by Region
Figure 45. Geographic Spread of Worldwide Point of Care (PoC) Molecular Diagnostics Market, 2019-2030, % of Sales Revenue
Figure 46. Global Addressable Market Cap in 2020-2030 by Region, Value ($ mn) and Share (%)
Figure 47. Health Spending as a Share of GDP by Country, 2015 and 2030
Figure 48. North American Point of Care (PoC) Molecular Diagnostics Market, 2019-2030, $ mn
Figure 49. Breakdown of North America Point of Care (PoC) Molecular Diagnostics Market by Country, 2019 and 2030, % of Revenue
Figure 50. Contribution to North America 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 51. U.S. Point of Care (PoC) Molecular Diagnostics Market, 2019-2030, $ mn
Figure 52. Canada Point of Care (PoC) Molecular Diagnostics Market, 2019-2030, $ mn
Figure 53. Point of Care (PoC) Molecular Diagnostics Market in Mexico, 2015-2030, $ mn
Figure 54. European Point of Care (PoC) Molecular Diagnostics Market, 2019-2030, $ mn
Figure 55. Breakdown of European Point of Care (PoC) Molecular Diagnostics Market by Country, 2019 and 2030, % of Revenue
Figure 56. Contribution to Europe 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 57. Point of Care (PoC) Molecular Diagnostics Market in Germany, 2019-2030, $ mn
Figure 58. Point of Care (PoC) Molecular Diagnostics Market in UK, 2019-2030, $ mn
Figure 59. Point of Care (PoC) Molecular Diagnostics Market in France, 2019-2030, $ mn
Figure 60. Point of Care (PoC) Molecular Diagnostics Market in Spain, 2019-2030, $ mn
Figure 61. Point of Care (PoC) Molecular Diagnostics Market in Italy, 2019-2030, $ mn
Figure 62. Point of Care (PoC) Molecular Diagnostics Market in Russia, 2019-2030, $ mn
Figure 63. Point of Care (PoC) Molecular Diagnostics Market in Rest of Europe, 2019-2030, $ mn
Figure 64. Asia-Pacific Point of Care (PoC) Molecular Diagnostics Market, 2019-2030, $ mn
Figure 65. Breakdown of APAC Point of Care (PoC) Molecular Diagnostics Market by Country, 2019 and 2030, % of Revenue
Figure 66. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 67. Point of Care (PoC) Molecular Diagnostics Market in Japan, 2019-2030, $ mn
Figure 68. Point of Care (PoC) Molecular Diagnostics Market in China, 2019-2030, $ mn
Figure 69. Point of Care (PoC) Molecular Diagnostics Market in Australia, 2019-2030, $ mn
Figure 70. Point of Care (PoC) Molecular Diagnostics Market in India, 2019-2030, $ mn
Figure 71. Point of Care (PoC) Molecular Diagnostics Market in South Korea, 2019-2030, $ mn
Figure 72. Point of Care (PoC) Molecular Diagnostics Market in Rest of APAC, 2019-2030, $ mn
Figure 73. South America Point of Care (PoC) Molecular Diagnostics Market, 2019-2030, $ mn
Figure 74. Breakdown of South America Point of Care (PoC) Molecular Diagnostics Market by Country, 2019 and 2030, % of Revenue
Figure 75. Contribution to South America 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 76. Point of Care (PoC) Molecular Diagnostics Market in Argentina, 2019-2030, $ mn
Figure 77. Point of Care (PoC) Molecular Diagnostics Market in Brazil, 2019-2030, $ mn
Figure 78. Point of Care (PoC) Molecular Diagnostics Market in Chile, 2019-2030, $ mn
Figure 79. Point of Care (PoC) Molecular Diagnostics Market in Rest of South America, 2019-2030, $ mn
Figure 80. Point of Care (PoC) Molecular Diagnostics Market in Middle East and Africa (MEA), 2019-2030, $ mn
Figure 81. Breakdown of MEA Point of Care (PoC) Molecular Diagnostics Market by Country, 2019 and 2030, % of Revenue
Figure 82. Contribution to MEA 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 83. Point of Care (PoC) Molecular Diagnostics Market in UAE, 2019-2030, $ mn
Figure 84. Point of Care (PoC) Molecular Diagnostics Market in Saudi Arabia, 2019-2030, $ mn
Figure 85. Point of Care (PoC) Molecular Diagnostics Market in South Africa, 2019-2030, $ mn
Figure 86. Growth Stage of Global Point of Care (PoC) Molecular Diagnostics Industry over the Forecast Period
Note: Product cover images may vary from those shown
3 of 4
  • Abacus Diagnostica Oy
  • Abbott Laboratories
  • Alere Inc.
  • Biocartis Group NV
  • Biomerieux SA
  • Bio-Rad Laboratories Inc
  • Danaher Corporation
  • DiaSorin S.p.A
  • DxNA LLC.
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Luminex Corporation
  • Meridian Bioscience Inc.
  • Mesa Biotech Inc.
  • QIAGEN N.V.
  • QuantuMDx Group Ltd.
  • Quidel Corporation
  • Spartan Biosciences Inc.
  • Thermo Fisher Scientific
Note: Product cover images may vary from those shown
4 of 4

Loading
LOADING...

Adroll
adroll